COVID-19 Information

Edit Entry | Edit CV

Mark A Cervinski, PhD

Title(s):
Associate Professor of Pathology and Laboratory Medicine

Additional Titles/Positions/Affiliations:
Director of Clinical Chemistry
Director of Point-Of-Care Testing
Diplomate of the American Board of Clinical Chemistry
Fellow, AACC Academy

Department(s):
Pathology and Laboratory Medicine

Education:
Ph.D. Biochemistry and Molecular Biology, 2006
University of North Dakota School of Medicine and Health Sciences

Clinical Chemistry Fellowship, 2007-2009
Washington University School of Medicine

Contact Information:

Department of Pathology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756

Phone: 603 650 7114
Fax: 603 650 4845
Email: mark.a.cervinski@hitchcock.org


Professional Interests:

General Clinical Chemistry
Laboratory Test Utilization Management
Real Time Patient Based Quality Control
Human Chorionic Gonadotropin
Toxicology

Courses Taught:

Director of ComACC Accredited Clinical Chemistry Fellowship Program
Lecturer for the Geisel School of Medicine General Pathology Course

Biography:

Mark Cervinski Ph.D DABCC, originally from Bonnyville, Alberta Canada received his Ph.D. in Biochemistry and Molecular Biology from the University of North Dakota in Grand Forks, North Dakota in 2006. Following his Ph.D. training Dr. Cervinski shifted his focus from the basic sciences to clinical chemistry and completed a Fellowship in Clinical Chemistry from Washington University in St. Louis in the summer of 2009. Mark joined the Department of Pathology and Laboratory Medicine as an Assistant Professor and as the Director of Clinical Chemistry at Dartmouth-Hitchcock Medical Center in August of 2009. Among diverse interests in clinical chemistry and laboratory medicine Dr. Cervinski is currently focused on using patient data as a supplementary quality control strategy, as well as test utilization/optimization and finding efficiencies in delivering laboratory results.

Mentoring Information:

Director of the Clinical Chemistry Fellowship program at DHMC
http://www.comacc.org/training/Pages/Dartmouth_Hitchcock.html


Selected Publications:

 

Pushing Patient-Based Quality Control Forward through Regression.
Cervinski MA
Clin Chem. 2021 Oct 1;67(10):1299-1300. doi: 10.1093/clinchem/hvab155.
PMID: 34487154

Gamma Glutamyl Transferase Activity Has Limited Utility in Assessment of Alkaline Phosphatase Elevations.
Geno KA, Poore B, Cervinski MA, Nerenz RD
J Appl Lab Med. 2021 Nov 1;6(6):1623-1627. doi: 10.1093/jalm/jfab085.
PMID: 34414431

An Unexpectedly Normal Sweat Chloride.
Javanbakht A, Kelliher MT, Poore BA, Harris VS, Cervinski MA
Clin Chem. 2021 Jul 6;67(7):1037-1038. doi: 10.1093/clinchem/hvab018.
PMID: 34229341

A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.
Poore B, Nerenz RD, Brodis D, Brown CI, Cervinski MA, Hubbard JA
Clin Biochem. 2021 Sep;95:77-80. doi: 10.1016/j.clinbiochem.2021.05.011. Epub 2021 Jun 9.
PMID: 34118242

Average of Patient Deltas: Patient-Based Quality Control Utilizing the Mean Within-Patient Analyte Variation.
Cembrowski GS, Xu Q, Cervinski MA
Clin Chem. 2021 Jul 6;67(7):1019-1029. doi: 10.1093/clinchem/hvab057.
PMID: 33993233

Evaluation of Thyroid Function in Pregnant Women Using Automated Immunoassays.
Geno KA, Reed MS, Cervinski MA, Nerenz RD
Clin Chem. 2021 Apr 29;67(5):772-780. doi: 10.1093/clinchem/hvab009.
PMID: 33928365

Current Testing Strategies for SARS-CoV-2 in the United States.
Cervinski MA, Parnas ML, Buxton BP, Choi J, Garner O, Neath SX, Zreloff JL
Clin Chem. 2021 Jul 6;67(7):935-940. doi: 10.1093/clinchem/hvab046.
PMID: 33822921

Reducing dermal exposure to agrochemical carcinogens using a fluorescent dye-based intervention among subsistence farmers in rural Honduras.
Flynn TG, Dunaway CM, LaRochelle E, Lyons K, Kennedy LS, Romano ME, Li Z, Spaller MR, Cervinski MA, Bejarano S, Tsongalis GJ, Huyck KL
Int J Hyg Environ Health. 2021 May;234:113734. doi: 10.1016/j.ijheh.2021.113734. Epub 2021 Mar 31.
PMID: 33799075

A Case of Persistently Low Hemoglobin A1c with Normal Plasma Glucose Concentrations.
Tsai C, Levy LC, Cervinski MA, Liu SK
J Appl Lab Med. 2021 Sep 1;6(5):1376-1379. doi: 10.1093/jalm/jfab009.
PMID: 33778870

Benefits, limitations, and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice.
van Rossum HH, Bietenbeck A, Cervinski MA, Katayev A, Loh TP, Badrick TC
Clin Chem Lab Med. 2021 Mar 10; doi: 10.1515/cclm-2021-0072. Epub 2021 Mar 10.
PMID: 33691350

View more publications on PubMed